Montgic-LC Tablet is a fixed-dose combination medication containing 5mg of levocetirizine and 10mg of montelukast. It is indicated for the treatment of patients with chronic idiopathic urticaria, allergic rhinitis, and asthma. Levocetirizine, an antihistamine, provides rapid and sustained relief from pruritus, while montelukast, an leukotriene receptor antagonist, inhibits the production of cysteinyl leukotrienes, key mediators of bronchoconstriction and inflammation. The combination of these two agents offers comprehensive relief from symptoms, including itching, sneezing, runny nose, congestion, and cough. Montgic-LC Tablet is available in a standardized tablet form, making it easy to administer and convenient for patients to take as directed. It is generally well-tolerated and has a favorable safety profile, with most common side effects being mild and transient. As a fixed-dose combination, Montgic-LC Tablet simplifies treatment regimens and reduces the need for multiple medications, making it an attractive option for healthcare providers seeking to manage complex respiratory and allergic conditions.